News | February 20, 2021
Zydus Cadila receives final approval from USFDA for Droxidopa capsules
It is used to treat low blood pressure that causes severe dizziness or a lightheaded feeling.
It is used to treat low blood pressure that causes severe dizziness or a lightheaded feeling.
These results were consistent across all clinically relevant patient subgroups regardless of key patient characteristics like age or sex, the cause of stroke or the severity of the stroke
The pharmaceutical giant said it would pursue legal and regulatory action following Hims & Hers
The FDA’s regulatory decision is expected in Q2 2026 under the Prescription Drug User Fee Act (PDUFA)
Topiramate Extended-Release Capsules are bioequivalent to the reference listed drug (RLD), Trokendi XR Extended-Release Capsules of Supernus Pharmaceuticals
Operating profit fell 1% in Danish kroner to DKK 127.7 billion but rose 6% at constant exchange rates
A PRV is a tradable voucher granted by the FDA to encourage the development of new treatments for rare pediatric diseases
Excluding Vacaville-related business, organic CER sales growth reached the low-teens with improved CORE EBITDA margins, in line with Lonza’s CDMO Organic Growth Model
Subscribe To Our Newsletter & Stay Updated
